NasdaqCM - Nasdaq Real Time Price USD

bioAffinity Technologies, Inc. (BIAFW)

Compare
0.4825
+0.0525
+(12.21%)
At close: January 10 at 4:00:00 PM EST
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
9,367.7850
2,532.4990
4.8030
--
--
Cost of Revenue
6,086.1680
1,740.8840
0.4670
--
--
Gross Profit
3,281.6170
791.6150
4.3360
--
--
Operating Expense
11,630.9140
8,764.8430
4,015.3940
2,206.8220
2,604.3850
Operating Income
-8,349.2970
-7,973.2280
-4,011.0580
-2,206.8220
-2,604.3850
Net Non Operating Interest Income Expense
-67.0530
85.0060
-2,485.9320
-1,001.4300
-381.0980
Other Income Expense
-15.8050
-27.7960
-1,654.6640
-3,116.2110
-4,280.5040
Pretax Income
-8,432.1550
-7,916.0180
-8,151.6540
-6,324.4630
-7,265.9870
Tax Provision
13.9430
20.9930
2.4590
1.9500
2.7500
Net Income Common Stockholders
-8,446.0980
-7,937.0110
-8,154.1130
-6,326.4130
-7,268.7370
Diluted NI Available to Com Stockholders
-8,446.0980
-7,937.0110
-8,154.1130
-6,326.4130
-7,268.7370
Total Operating Income as Reported
-8,349.2970
-7,973.2280
-4,011.0580
-2,206.8220
-2,604.3850
Total Expenses
17,717.0820
10,505.7270
4,015.8610
2,206.8220
2,604.3850
Net Income from Continuing & Discontinued Operation
-8,446.0980
-7,937.0110
-8,154.1130
-6,326.4130
-7,268.7370
Normalized Income
-8,446.0980
-7,937.0110
-8,366.3710
-3,522.3815
-7,268.7370
Interest Income
25.7010
122.1310
46.7080
0.4240
1.0730
Interest Expense
92.7540
37.1250
2,532.6400
1,001.8540
382.1710
Net Interest Income
-67.0530
85.0060
-2,485.9320
-1,001.4300
-381.0980
EBIT
-8,339.4010
-7,878.8930
-5,619.0140
-5,322.6090
-6,883.8160
EBITDA
-7,738.6090
-7,629.3010
-5,608.8320
-5,317.7920
-6,861.5740
Reconciled Cost of Revenue
6,086.1680
1,740.8840
0.4670
--
--
Reconciled Depreciation
600.7920
249.5920
10.1820
4.8170
22.2420
Net Income from Continuing Operation Net Minority Interest
-8,446.0980
-7,937.0110
-8,154.1130
-6,326.4130
-7,268.7370
Total Unusual Items Excluding Goodwill
--
--
212.2580
-3,841.1390
--
Total Unusual Items
--
--
212.2580
-3,841.1390
--
Normalized EBITDA
-7,738.6090
-7,629.3010
-5,821.0900
-1,476.6530
-6,861.5740
Tax Rate for Calcs
0.0002
--
--
0.0003
0.0003
Tax Effect of Unusual Items
--
--
--
-1,037.1075
--
-

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ICBU iMD Companies, Inc.
0.0024
+9.09%
 
BDSX Biodesix, Inc.
1.2700
-14.19%
 
PRPH ProPhase Labs, Inc.
0.6490
+10.19%
 
CDNA CareDx, Inc
23.63
-1.54%
 
DGX Quest Diagnostics Incorporated
151.79
-1.45%
 
VCYT Veracyte, Inc.
41.54
-5.12%
 
FLGT Fulgent Genetics, Inc.
18.31
-2.86%
 
CSTL Castle Biosciences, Inc.
30.25
-7.55%
 
IDXX IDEXX Laboratories, Inc.
418.05
-3.31%
 
NTRA Natera, Inc.
175.00
-0.91%